首页> 外国专利> Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain

Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain

机译:通过操纵共同的细胞因子受体γ链抑制T细胞反应的方法

摘要

When stimulated through the T cell receptor(TCR)/CD3 complex without requisite costimulation through the CD28/B7 interaction, T cells enter a state of antigen specific unresponsiveness or anergy. This invention is based, at least in part, on the discovery that signaling though a common cytokine receptor &ggr; chain (e.g., interleukin-2 receptor, interleukin-4 receptor, interleukin-7 receptor, interleukin-15 receptor) prevents the induction of T cell anergy. This &ggr; chain has been found to be associated with a JAK3 kinase having a molecular weight of about 116 kD (as determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis) and signaling through the &ggr; chain induces phosphorylation of the JAK3 kinase. Accordingly, methods for stimulating or inhibiting proliferation by a T cell which expresses a cytokine receptor &ggr; chain are disclosed.
机译:当通过T细胞受体(TCR)/ CD3复合物刺激而无需通过CD28 / B7相互作用进行必要的共同刺激时,T细胞进入抗原特异性无反应性或无反应状态。本发明至少部分地基于以下发现:通过共同的细胞因子受体发出信号。链(例如白介素2受体,白介素4受体,白介素7受体,白介素15受体)阻止了T细胞无反应性的诱导。这个&ggr;已发现该链与分子量约为116kD的JAK3激酶有关(由十二烷基硫酸钠聚丙烯酰胺凝胶电泳测定),并通过&ggr信号传导。链诱导JAK3激酶的磷酸化。因此,通过表达细胞因子受体的T细胞刺激或抑制增殖的方法。链被公开。

著录项

  • 公开/公告号US2002127201A1

    专利类型

  • 公开/公告日2002-09-12

    原文格式PDF

  • 申请/专利权人 DANA-FARBER CANCER INSTITUTE.;

    申请/专利号US20020141199

  • 发明设计人 LEE M. NADLER;VASSILIKI A. BOUSSIOTIS;

    申请日2002-05-07

  • 分类号A61K39/395;A61K39/02;A61K39/12;A61K39/00;A61K38/20;

  • 国家 US

  • 入库时间 2022-08-22 00:53:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号